Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
RevMab
anti-p42 MAPK (Erk2), Rabbit Monoclonal (RM483)
As low as
468
CHF
CHF 468.00
In stock
Only %1 left
REV-31-1375-00-R100100 µlCHF 468.00
Figure 1: Immunohistochemical staining of formalin-fixed and paraffin-embedded human Lung Squamous Carcinoma tissue sections using Anti-Erk2 antibody (RM483) at 1:100 dilution.
Figure 2: Western Blot of 293 cell lysate using Anti-Erk2 antibody (RM483) at 1:2000 dilution.
| Product Details | |
|---|---|
| Synonyms | Mitogen-activated Protein Kinase Isoform p42; Extracellular Signal-regulated Kinase 2 |
| Product Type | Recombinant Antibody |
| Properties | |
| Clone | RM483 |
| Isotype | Rabbit IgG |
| Source/Host | Rabbit |
| Immunogen/Antigen | A peptide corresponding to the C-terminus of human p42-MAPK (Erk2). |
| Application |
Immunohistochemistry (IHC): 1:100-1:200 |
| Crossreactivity |
Human Mouse Rat |
| Specificity |
This antibody reacts to human p42 MAPK (Erk2). This antibody may also react to mouse or rat Erk2 as predicted by immunogen homology. |
| Purity | Protein A purified. |
| Purity Detail | Protein A affinity purified from an animal origin-free culture supernatant. |
| Concentration | N/A |
| Formulation | Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide. |
| Isotype Negative Control | |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| Accession Number | P28482 |
| Declaration | Manufactured by RevMab Biosciences. |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Long Term Storage | -20°C |
| Handling Advice | Avoid freeze/thaw cycles. |
| Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
| Documents | |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
Extracellular signal-regulated kinases 1 and 2 (also known as ERK1/2, p44/42, or MAPK3/1) belong to a family of conserved serine/threonine protein kinases known as mitogen-activated protein kinases (MAPKs) that are involved in many cellular programs such as proliferation, differentiation, motility and survival. The ERK1/2 signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors and cytokines. The primary activators of ERK1/2 are MEK1 and MEK2 which activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187 in ERK1 and ERK2, respectively. Several downstream targets of ERK1/2 have been identified, including p90RSK and the transcription factor Elk-1. ERK1/2 are negatively regulated by MAPK phosphatases as well as by chemical inhibitors of MEK. The ERK pathway is disrupted in many types of cancer and thus is an important target for diagnosis and treatment.
Related Products
